Breakthrough hepatitis C drug from Gilead Sciences offers faster cure and fewer side effects

  • by: MATTHEW PERRONE , Associated Press
  • Updated: December 6, 2013 - 11:58 PM

WASHINGTON — Federal health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences Inc. that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT